Stay updated on Pembrolizumab in Neuroendocrine Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Neuroendocrine Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Neuroendocrine Tumors Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T16:46:17.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added to the page. The government funding status warning banner about potential outages has been removed.
    Difference
    0.5%
    Check dated 2026-02-11T09:17:08.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A government funding status notice was added indicating the NIH Clinical Center is open and updates can be found at external sites. The page revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T05:24:33.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    UI and data metadata changes include adding a glossary display option and updating labels such as 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while removing the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T03:41:24.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision history updated to v3.3.4, replacing v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:41:59.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a Locations section listing Pennsylvania and Texas as study sites, replacing the former Pennsylvania Locations and Texas Locations entries.
    Difference
    0.4%
    Check dated 2025-12-23T13:41:58.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Neuroendocrine Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Neuroendocrine Tumors Clinical Trial page.